Traditional approval of encorafenib plus cetuximab and fluorouracil-based chemotherapy for patients with BRAF-mutated ...

The FDA has approved the first combination, targeted regimen for previously untreated BRAF V600E mutation-positive metastatic ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to ...

The U.S. Food and Drug Administration (FDA) has granted traditional approval to Braftovi (encorafenib) for adult patients ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in ...

The anti-PD-L1 monoclonal antibody sugemalimab was developed by CStone using OmniRat® transgenic animal platform, which allows creation of fully human antibodies in one step. Sugemalimab is a fully ...

SUZHOU, China, Feb. 23, 2026 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for ...

Pineapple is a healthy snack — but bromelain, an enzyme in this fruit, may interact with certain medications, including some ...

AI in oncology nursing remains in its early stages, but it’s already reshaping health care. This moment was evident at the 2025 American Society of Hematology Annual Meeting and Exposition, which ...

NICRAT scales up targeted screening, preventionSkin cancer is emerging as a growing public health threat among Nigerians living with albinism, as prolonged exposure to intense ultraviolet (UV) ...

Patients are traveling thousands of miles to Sarasota for one specific procedure and one specific surgeon. Florida Plastic Surgery ...

KinderSystems announced its technology was referenced during a recent U.S. Senate hearing, "Restoring Integrity: Preventing Fraud in Child Care Assistance Programs," focused on improving oversight, ...